KNect365 Life Sciences is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Who Will Be the Next Celgene of Dealmaking? VCs, Entrepreneurs Size Up Partners

Let's face it, Celegene was an important market maker for partnering deals. That is why many a biotech (and their investors) lament the day Celegene was acquired by BMS. So what happens now? Will the deal flow void be filled by other companies? If so, which ones?

These are the questions that respected industry reporter and prognosticator, Luke Timmerman, contemplates in this worthwhile article.

"Who Will Be the Next Celgene of Dealmaking?
VCs, Entrepreneurs Size Up Partners"

200x200 (62)

who-will-be-the-next-celgene-of-dealmaking-vcs-entrepreneurs-size-up-partners-EBD-Group-BioPharm-America-2

Download the full article for an inside look at some of the candidates for “most aggressive” in biopharma business development. If you’re lucky, you might be able to schedule a meeting with someone from one of these companies at BioPharm America™, coming up Sept. 11–12 in Boston.

Who Will Be the Next Celgene of Dealmaking? VCs, Entrepreneurs Size Up Partners - EBD Group

Join our monthly newsletter!